Member Login
Home
About Us
Officers
Contact Us
Corporate Members
Become a Corporate Member
Events
2024 Annual Meeting Exhibitors
Targeted Oncology™ Community Case Forum™ - April 25
Virtual CME - May 7
Past Annual Meeting Highlights
Membership
Resources
Job Bank
Advertise a Job
FDA Approvals
Podcasts
Find an Oncologist
Useful Links
Corporate Members
FDA Approvals
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
FDA has approved BOSULIF (bosutinib) for a new indication and has also approved a new formulation.
Home
About Us
Officers
Contact Us
Corporate Members
Become a Corporate Member
Events
2024 Annual Meeting Exhibitors
Targeted Oncology™ Community Case Forum™ - April 25
Virtual CME - May 7
Past Annual Meeting Highlights
Membership
Resources
Job Bank
Advertise a Job
FDA Approvals
Podcasts
Find an Oncologist
Useful Links
Pennsylvania Society of Oncology and Hematology